This database is populated with information on the results of Roche-sponsored clinical trials.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: III A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients with Metastatic Pancreatic Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: III A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients with Colon Cancer
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: IV A Study of Avastin (Bevacizumab) in Combination with Chemotherapy in Patients with Metastatic Cancer of the Colon or Rectum
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II Modified-dose capecitabine (Xeloda) plus bevacizumab (Avastin) for the treatment of advanced or metastatic hepatocellular carcinoma (HCC): a phase II, single-arm study
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients with Metastatic Cancer of the Colon or Rectum
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: III A Study of Avastin (Bevacizumab) in Women with HER2 Negative Metastatic Breast Cancer
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) in Patients with Multiple Myeloma
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) in Combination with Chemotherapy in Patients with Primary breast Cancer
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) and Oxalplatin Plus Xeloda (Capacitabine) in Patients With Advanced Colorectal Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: III A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: III A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: IV ATHENA Study: A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: III A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) in Elderly Patients With Metastatic Colorectal Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: IV A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: III A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) in Combination With Dacarbazine in Patients With Unresectable/Metastatic Melanoma.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) in Combination With Fortemustine in Patients With Metastatic Melanoma.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) in Patients With Newly Diagnosed Locally Advanced Rectal Cancer.
Product Name: Avastin [bevacizumab] Date of Report: 3/1/2007 Phase: III A randomized, double-blind, phase III study to evaluate the efficacy and safety of bevacizumab in combination with interferon alfa-2a (Roferon) versus interferon alfa-2a and placebo as first line treatment administered to nephrectomised patients with metastatic clear cell renal cell carcinoma.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.
Product Name: Avastin [bevacizumab] Date of Report: 5/1/2007 Phase: IV A single arm study to assess the efficacy and safety of bevacizumab in combination with irinotecan and infusional 5-fluorouracil/folic acid regimens as first line treatment for patients with metastatic colorectal cancer.
Product Name: Avastin [bevacizumab] Date of Report: 6/1/2007 Phase: III A randomized double-blind multicenter phase III study of bevacizumab in combination with cisplatin and gemcitabine versus placebo, cisplatin and gemcitabine in patients with advanced or recurrent non-squamous non-small cell lung cancer, who have not received prior chemotherapy.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: III A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: III A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Cisplatin in Patients With Advanced Gastric Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: III BEATRICE Study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: IV OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) and TACE Treatment in Patients With Liver Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: III A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients WIth Metastatic Colorectal Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Genetic Substudy Associated With the Avastin {Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: III A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients WIth Metastatic Colorectal Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: III BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.
Product Name: Avastin [bevacizumab] Date of Report: 4/18/2008 Phase: II A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-Small Cell Lung Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: IV A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: III A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) in Combination With XELOX Patients With Metastatic Colorectal Cancer.
Product Name: Avastin [bevacizumab] Date of Report: To be Published Phase: II A Study of Avastin (Bevacizumab) plus Herceptin (Trastuzumab) in Patients WIth Primary Inflammatory HER2-Positive Breast Cancer.
© 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement
© 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement